Cargando…

Commissioning and validation of RayStation treatment planning system for CyberKnife M6

BACKGROUND: RaySearch (AB, Stockholm) has released a module for CyberKnife (CK) planning within its RayStation (RS) treatment planning system (TPS). PURPOSE: To create and validate beam models of fixed, Iris, and multileaf collimators (MLC) of the CK M6 for Monte Carlo (MC) and collapsed cone (CC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondré, Maude, Conrad, Mireille, Vallet, Véronique, Bourhis, Jean, Bochud, François, Moeckli, Raphaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359029/
https://www.ncbi.nlm.nih.gov/pubmed/35856911
http://dx.doi.org/10.1002/acm2.13732
_version_ 1784764053099380736
author Gondré, Maude
Conrad, Mireille
Vallet, Véronique
Bourhis, Jean
Bochud, François
Moeckli, Raphaël
author_facet Gondré, Maude
Conrad, Mireille
Vallet, Véronique
Bourhis, Jean
Bochud, François
Moeckli, Raphaël
author_sort Gondré, Maude
collection PubMed
description BACKGROUND: RaySearch (AB, Stockholm) has released a module for CyberKnife (CK) planning within its RayStation (RS) treatment planning system (TPS). PURPOSE: To create and validate beam models of fixed, Iris, and multileaf collimators (MLC) of the CK M6 for Monte Carlo (MC) and collapsed cone (CC) algorithms in the RS TPS. METHODS: Measurements needed for the creation of the beam models were performed in a water tank with a stereotactic PTW 60018 diode. Both CC and MC models were optimized in RS by minimizing the differences between the measured and computed profiles and percentage depth doses. The models were then validated by comparing dose from the plans created in RS with both single and multiple beams in different phantom conditions with the corresponding measured dose. Irregular field shapes and off‐axis beams were also tested for the MLC. Validation measurements were performed using an A1SL ionization chamber, EBT3 Gafchromic films, and a PTW 1000 SRS detector. Finally, patient‐specific QAs with gamma criteria of 3%/1 mm were performed for each model. RESULTS: The models were created in a straightforward manner with efficient tools available in RS. The differences between computed and measured doses were within ±1% for most of the configurations tested and reached a maximum of 3.2% for measurements at a depth of 19.5‐cm. With respect to all collimators and algorithms, the maximum averaged dose difference was 0.8% when considering absolute dose measurements on the central axis. The patient‐specific QAs led to a mean result of 98% of points fulfilling gamma criteria. CONCLUSIONS: We created both CC and MC models for fixed, Iris, and MLC collimators in RS. The dose differences for all collimators and algorithms were within ±1%, except for depths larger than 9 cm. This allowed us to validate both models for clinical use.
format Online
Article
Text
id pubmed-9359029
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93590292022-08-10 Commissioning and validation of RayStation treatment planning system for CyberKnife M6 Gondré, Maude Conrad, Mireille Vallet, Véronique Bourhis, Jean Bochud, François Moeckli, Raphaël J Appl Clin Med Phys Radiation Oncology Physics BACKGROUND: RaySearch (AB, Stockholm) has released a module for CyberKnife (CK) planning within its RayStation (RS) treatment planning system (TPS). PURPOSE: To create and validate beam models of fixed, Iris, and multileaf collimators (MLC) of the CK M6 for Monte Carlo (MC) and collapsed cone (CC) algorithms in the RS TPS. METHODS: Measurements needed for the creation of the beam models were performed in a water tank with a stereotactic PTW 60018 diode. Both CC and MC models were optimized in RS by minimizing the differences between the measured and computed profiles and percentage depth doses. The models were then validated by comparing dose from the plans created in RS with both single and multiple beams in different phantom conditions with the corresponding measured dose. Irregular field shapes and off‐axis beams were also tested for the MLC. Validation measurements were performed using an A1SL ionization chamber, EBT3 Gafchromic films, and a PTW 1000 SRS detector. Finally, patient‐specific QAs with gamma criteria of 3%/1 mm were performed for each model. RESULTS: The models were created in a straightforward manner with efficient tools available in RS. The differences between computed and measured doses were within ±1% for most of the configurations tested and reached a maximum of 3.2% for measurements at a depth of 19.5‐cm. With respect to all collimators and algorithms, the maximum averaged dose difference was 0.8% when considering absolute dose measurements on the central axis. The patient‐specific QAs led to a mean result of 98% of points fulfilling gamma criteria. CONCLUSIONS: We created both CC and MC models for fixed, Iris, and MLC collimators in RS. The dose differences for all collimators and algorithms were within ±1%, except for depths larger than 9 cm. This allowed us to validate both models for clinical use. John Wiley and Sons Inc. 2022-07-20 /pmc/articles/PMC9359029/ /pubmed/35856911 http://dx.doi.org/10.1002/acm2.13732 Text en © 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Gondré, Maude
Conrad, Mireille
Vallet, Véronique
Bourhis, Jean
Bochud, François
Moeckli, Raphaël
Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title_full Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title_fullStr Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title_full_unstemmed Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title_short Commissioning and validation of RayStation treatment planning system for CyberKnife M6
title_sort commissioning and validation of raystation treatment planning system for cyberknife m6
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359029/
https://www.ncbi.nlm.nih.gov/pubmed/35856911
http://dx.doi.org/10.1002/acm2.13732
work_keys_str_mv AT gondremaude commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6
AT conradmireille commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6
AT valletveronique commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6
AT bourhisjean commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6
AT bochudfrancois commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6
AT moeckliraphael commissioningandvalidationofraystationtreatmentplanningsystemforcyberknifem6